Table 3.
Unadjusted analysis of demographics and clinical characteristics of patients with AIDS versus non-AIDS deaths 1995-2011 (n=400).
| AIDS (n=175) | Non-AIDS (n=225) | p-value | |
|---|---|---|---|
| Median Age (IQR) | 40 (35-48) | 48 (42-55) | <0.0001 |
| Male gender | 115 (43.9) | 147 (56.1) | 0.94 |
| Race, n (%) | |||
| Black | 105 (60.3) | 133 (59.4) | 0.84 |
| White | 41 (23.6) | 64 (28.6) | 0.26 |
| Hispanic | 28 (16.1) | 27 (12.1) | 0.25 |
| On ART | 97 (55.8) | 160 (74.1) | 0.0001 |
| CD4<200 cells/mm3* (%) | 167 (97.1) | 95 (47.2) | <0.0001 |
| HIV VL≤400 copies/ml** (%) | 2 (4.1) | 75 (38.1) | <0.0001 |
| Comorbidities | |||
| Diabetes | 13 (7.4) | 35 (15.6) | 0.01 |
| Renal disease | |||
| CKD | 21 (12) | 73 (32.4) | <0.0001 |
| On dialysis | 9 (5.1) | 47 (20.9) | <0.0001 |
| Liver disease | |||
| Hepatitis C | 38 (21.7) | 130 (57.8) | <0.0001 |
| Cirrhosis | 14 (8) | 67 (29.8) | <0.0001 |
| Cardiovascular Disease | |||
| Hypertension | 18 (10.3) | 56 (24.9) | 0.0002 |
| CAD | 2 (1.1) | 16 (7.1) | 0.004 |
| CHF | 13 (7.4) | 29 (12.9) | 0.08 |
| COPD | 5 (2.9) | 17 (7.6) | 0.04 |
| Alcohol abuse | 9 (5.1) | 18 (8.0) | 0.26 |
| Polysubstance abuse | 10 (5.7) | 22 (9.8) | 0.14 |
CKD: Chronic kidney disease
CAD: Coronary Artery Disease
CHF: Congestive Heart Failure
COPD: Chronic Obstructive Pulmonary Disease
*
Last CD4 count > 200 cells/mm3 in the year prior to death
**
VL <400 copies/ml in the year prior to death